Cigarroa-Toledo Nohemi, Jiménez-Coello Matilde, García-Rejón Julián E, Chan-Pérez José I, Acosta-Viana Karla Y, Ortega-Pacheco Antonio, Pietri José E, Baak-Baak Carlos M
Laboratory of Cell Biology, Centro de Investigaciones Regionales "Dr. Hideyo Noguchi", Universidad Autónoma de Yucatán, Mérida, Yucatán, Mexico.
Laboratory of Arbovirology, Centro de Investigaciones Regionales "Dr. Hideyo Noguchi", Universidad Autónoma de Yucatán, Mérida, Yucatán, Mexico.
Gac Med Mex. 2022;158(6):349-354. doi: 10.24875/GMM.M22000712.
SARS-CoV-2 infection spatial and temporal distribution overlaps with endemic areas of vector-borne diseases (VBD), whose surveillance in Mexico has substantially changed since the first COVID-19 confirmed case.
To estimate and compare the incidence rates of VBDs before and after the introduction of SARS-CoV-2 in Mexico.
Retrospective study of VBD cases from 2014 to 2021. The incidence rates of each VBD in the period before (2014-2019) and after (2020-2021) the introduction of SARS-CoV-2 in Mexico were calculated and compared.
Before the introduction of SARS-CoV-2, the incidence rates of VBDs were high and after the introduction of coronavirus there was a decrease in epidemiological indices; however, there was only statistically significant difference in the incidence rate of malaria (p ≤ 0.05) and other rickettsiae (p ≤ 0.05).
Some measures to reduce COVID-19 cases, such as social distancing, home confinement, reductions in public transport and working at home (home office), probably temporarily decreased the number of VBD cases; however, there may be a resurgence of VBDs in the near future.
严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染的时空分布与媒介传播疾病（VBD）的流行地区重叠，自墨西哥首例新冠肺炎确诊病例以来，该国对VBD的监测发生了重大变化。
估计并比较墨西哥引入SARS-CoV-2前后VBD的发病率。
对2014年至2021年的VBD病例进行回顾性研究。计算并比较墨西哥引入SARS-CoV-2之前（2014 - 2019年）和之后（2020 - 2021年）各VBD的发病率。
在引入SARS-CoV-2之前，VBD的发病率较高，引入冠状病毒后，流行病学指标有所下降；然而，仅疟疾发病率（p≤0.05）和其他立克次氏体病发病率（p≤0.05）存在统计学显著差异。
一些减少新冠肺炎病例的措施，如社交距离限制、居家隔离、公共交通减少和居家办公，可能暂时减少了VBD病例数；然而，VBD在不久的将来可能会再次出现。
